SynthesisJournal of neuro-oncology2026
Transformation of vestibular schwannomas into malignant peripheral sheath tumors: a systematic review and pooled analysis of patient characteristics and survival outcomes.
Synthesis in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTransformation of vestibular schwannoma (VS) into malignant peripheral nerve sheath tumor (MPNST) is rare and poorly characterized. We have synthesized available evidence from the literature to define clinical features, transformation patterns, management strategies, and survival outcomes in patients with MPNST after histologically confirmed transformation from VS.
methodsA PRISMA-guided systematic review of PubMed, Scopus, and Google Scholar databases identified case reports and case series reporting histologically confirmed VSs transforming to MPNSTs with clinical and outcome data. Demographic, clinical, treatment, and survival variables were extracted and analyzed.
resultsTwenty-one studies comprised 24 patients (7 male) with MPNSTs (median age 52 years; 8% with neurofibromatosis 2-related schwannomatosis). The median interval from VS to MPNST diagnosis was 54.0 months; 75% of patients had prior radiation-based therapy for VS. The transformation interval was significantly shorter in patients with spontaneous transformation compared with those whose transformation occurred after radiation (7.2 vs. 84.0 months; p = 0.001). All patients underwent resection after their tumors transformed into MPNST; 42% received adjuvant radiation-based therapy. Median overall survival was 11.0 months, and adjuvant radiation-based therapy was associated with longer overall survival (15.6 vs. 4.0 months; p < 0.001) in all patients with MPNST. Age at diagnosis, sex, tumor size, tumor laterality, p53 status, and hydrocephalus occurrence were not associated with a statistically significant difference in overall survival. Recurrence or progression occurred in 60% of evaluable patients.
conclusionOnce transformation of VS into MPNST occurs, survival prognosis is bleak; however, these results indicate that early surgical intervention and adjunctive radiation-based therapy for MPNST may offer survival benefits despite high recurrence risk.
Indexed as
Identifiers
42599576What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.